I saw a healthy young woman this week in her 40s. She told me about a time in her life when she was struggling. She had diffuse muscular pain that progressed to the point where she couldn’t grip the steering wheel or hold a pencil. She had to take three months of medical leave from her corporate position.
She was referred to a rheumatologist at a prominent Boston hospital. The working diagnosis was “fibromyalgia.” The specialist put her on the pharmaceutical methotrexate, a drug originally developed for chemotherapy, but now more often used for autoimmune conditions like Rheumatoid Arthritis. The drug had no benefit for her.